Peptides9 min read
What would a convincing BPC-157 tendon trial look like?
A useful tendon trial must separate pain relief from recovery of strength and structure. Here is what the human evidence and new shoulder registration show.
Read articleBlog
Research, explained. Explore peptides, supplements, hormone health, longevity and red light therapy with clear, practical breakdowns of what the studies actually tell us.
Explore the articles
Find a topic you’re curious about and take a closer look.
Peptides8 min read
Can MOTS-c improve human endurance? What exercise studies have tested
Human MOTS-c exercise studies measured the body's own peptide; rodent treatment and analogue results answer different performance questions.
Read article
Peptides9 min read
Humanin and long-lived families: what the human comparison found
A small study found higher humanin in centenarians’ children. Other human studies complicate the story: context matters more than a simple high-or-low target.
Read article
Peptides8 min read
GHK-Cu after laser resurfacing: satisfaction and visible recovery
A small trial found higher satisfaction with GHK-Cu after laser resurfacing, but no significant added objective benefit. What does that mean for aftercare?
Read article
Peptides8 min read
GHRP-6 tolerance: what repeated-response studies actually measured
Repeated GHRP-6 studies show how GH secretion can persist while a later challenge response shrinks. Understand attenuation without inventing a cycle.
Read article
Peptides8 min read
IGF-binding proteins: the missing context in IGF-1 LR3 claims
Binding proteins help explain LR3's experimental activity, but weaker binding does not establish a longer human half-life or predictable benefits.
Read article
Peptides9 min read
Why muscle-damage markers cannot validate a PEG-MGF recovery claim
Creatine kinase, tissue repair and restored function answer different questions. Here is how to read MGF recovery research without skipping those differences.
Read article
Peptides9 min read
LL-37 and biofilms: attractive laboratory findings need clinical confirmation
Biofilm prevention, biomass and viable organisms are different outcomes. Explore what LL-37 experiments show and what clinical treatment claims still need.
Read article
Supplements9 min read
Synbiotics: does combining a probiotic with its food improve symptoms?
What whole-formula trials tell us about synbiotics, IBS and constipation—and why combining ingredients does not automatically demonstrate synergy.
Read article
Peptides8 min read
Sermorelin combinations: what a better hormone result can tell you
A small clinic study found higher IGF-1 with three peptides plus testosterone. Learn what it measured and why it cannot isolate sermorelin's benefit.
Read article
Supplements9 min read
Lion’s mane and brain fog: the gap between a mechanism and a useful trial
Lion’s mane has preliminary cognitive findings, but small mixed trials and laboratory mechanisms do not establish a remedy for brain fog.
Read article
Peptides8 min read
Is GHRP-6 natural? The molecule, the pathway and the safety question
GHRP-6 is synthetic, even though it stimulates an endogenous hormone pathway. Understand what natural-origin claims leave out about identity, feedback and safety.
Read article554–565 of 600 articles